22 February 2019 | News
Also offered are advanced packages for men and women, with a complete assessment by the doctor.
Lucid Diagnostics, a premier diagnostics company and Mapmygenome, a molecular diagnostics company have announced their alliance to advance cutting-edge, personalized and preventive medicine by combining genomics and pathology lab services. Lucid will offer DNA Onco Screen to customers and physicians for prevention and early detection of cancers.
“Genetics is an important part of clinical diagnostics and we are pleased to offer these packages with Mapmygenome,” said Dr Sunitha Lingareddy, Managing Director, Lucid Diagnostics. “We are quite excited about this partnership,” said Anu Acharya, CEO, Mapmygenome. “Combining clinical parameters with genomics makes it very compelling for physicians and consumers to get a comprehensive screen.”
DNA Onco Screen assesses genetic predisposition to various cancers, physiological traits known to trigger cancer, and lifestyle traits linked to cancer risk. Key clinical markers associated with cancer are also tested. Also offered are advanced packages for men and women, with a complete assessment by the doctor. All packages include genetic counselling to help understand individuals’ risk of cancer, inheritance patterns, and lifestyle changes essential to prevent cancer. These packages are the most effective, efficient, and comprehensive cancer screening tests available in the country.
Lucid provides a comprehensive suite of healthcare services and health check-up packages to aid accurate as well as timely diagnosis. Lucid Lab has been accredited with both NABL and CAP to achieve highest standards of excellence and positively impact patient care. Lucid has been awarded Best Diagnostics in the year 2018 by both Times Healthcare and Pharma Leaders at both State and National level. Now Lucid is striving to become a Centre of Excellence in Advanced Imaging as well as research by collaborating with institutes like LVP; Companies like Aizant, Admirus, Juventa, Sristek, and Indian Immunologicals Ltd. Currently, we are running 69 Centers in the states of Telangana, Andhra Pradesh, Karnataka and shortly expanding to have Pan India as well as International presence.
Mapmygenome is a molecular diagnostics company that enables people to be proactive about their health. They offer personalized health solutions based on genetic tests that help people get to know themselves. By combining genetic health profiles, health history, and genetic counseling, Mapmygenome provides actionable steps for healthier lives. Services offered include personal genomics, clinical sequencing, Indian genome databases, infectious disease kits and services, research services, and genetic counselling. Founded in 2013, Mapmygenome started as India’s pioneering Personal Genomics Company with a vision to “Touch 100 million lives and save a million lives by 2030.”